A rare case of tamoxifen-induced thrombocytopenia

Anurag Pathak, Sushil Kiran Kunder, A. Avinash, Navin Patil, N. Karthik Rao

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.

Original languageEnglish
Pages (from-to)156-157
Number of pages2
JournalJournal of Applied Pharmaceutical Science
Volume6
Issue number1
DOIs
Publication statusPublished - 01-01-2016

Fingerprint

Tamoxifen
Thrombocytopenia
Breast Neoplasms
Selective Estrogen Receptor Modulators
Chemoprevention
Palliative Care
Pharmaceutical Preparations
Early Diagnosis
Blood Platelets
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Pathak, Anurag ; Kunder, Sushil Kiran ; Avinash, A. ; Patil, Navin ; Rao, N. Karthik. / A rare case of tamoxifen-induced thrombocytopenia. In: Journal of Applied Pharmaceutical Science. 2016 ; Vol. 6, No. 1. pp. 156-157.
@article{f0973d349acb4fda85b38348ee9fb85a,
title = "A rare case of tamoxifen-induced thrombocytopenia",
abstract = "Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.",
author = "Anurag Pathak and Kunder, {Sushil Kiran} and A. Avinash and Navin Patil and Rao, {N. Karthik}",
year = "2016",
month = "1",
day = "1",
doi = "10.7324/JAPS.2016.600125",
language = "English",
volume = "6",
pages = "156--157",
journal = "Journal of Applied Pharmaceutical Science",
issn = "2231-3354",
publisher = "MediPoeia",
number = "1",

}

A rare case of tamoxifen-induced thrombocytopenia. / Pathak, Anurag; Kunder, Sushil Kiran; Avinash, A.; Patil, Navin; Rao, N. Karthik.

In: Journal of Applied Pharmaceutical Science, Vol. 6, No. 1, 01.01.2016, p. 156-157.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A rare case of tamoxifen-induced thrombocytopenia

AU - Pathak, Anurag

AU - Kunder, Sushil Kiran

AU - Avinash, A.

AU - Patil, Navin

AU - Rao, N. Karthik

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.

AB - Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.

UR - http://www.scopus.com/inward/record.url?scp=84957631159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957631159&partnerID=8YFLogxK

U2 - 10.7324/JAPS.2016.600125

DO - 10.7324/JAPS.2016.600125

M3 - Article

VL - 6

SP - 156

EP - 157

JO - Journal of Applied Pharmaceutical Science

JF - Journal of Applied Pharmaceutical Science

SN - 2231-3354

IS - 1

ER -